aiqbench analysis
This research proposes multi-agent algorithms to coordinate swarms of nanobots for treating diffuse cancers by optimizing drug delivery based on chemical gradient signals. The study models the stochastic movement of nanoparticles in colloidal environments, evaluating strategies ranging from natural chemotaxis to active signal amplification and repulsion mechanisms. While the application is biomedical, the core contribution lies in developing mathematical frameworks for swarm coordination and autonomous agent behavior within complex biological constraints.
Nanobot Algorithms for Treatment of Diffuse Cancer
arXiv:2509.06893v2 Announce Type: replace-cross Abstract: Motile nanosized particles, or "nanobots", promise more effective and less toxic targeted drug delivery because of their unique scale and precision. We consider the case in which the cancer is "diffuse", dispersed such that there are multiple distinct cancer sites. We investigate the problem of a swarm of nanobots locating these sites and treating them by dropping drug payloads at the sites. To improve the success of the treatment, the drug payloads must be allocated between sites according to their "demands"; this requires extra nanobot coordination. We present a mathematical model of the behavior of the nanobot agents and of their colloidal environment. This includes a movement model for agents based upon experimental findings from actual nanoparticles in which bots noisily ascend and descend chemical gradients. We present three algorithms: The first algorithm, called KM, is the most representative of reality, with agents simply following naturally existing chemical signals that surround each cancer site. The second algorithm, KMA, includes an additional chemical payload which amplifies the existing natural signals. The third algorithm, KMAR, includes another additional chemical payload which counteracts the other signals, instead inducing negative chemotaxis in agents such that they are repelled from sites that are already sufficiently treated. We present simulation results for all algorithms across different types of cancer arrangements. For KM, we show that the treatment is generally successful unless the natural chemical signals are weak, in which case the treatment progresses too slowly. For KMA, we demonstrate a significant improvement in treatment speed but a drop in eventual success, except for concentrated cancer patterns. For KMAR, our results show great performance across all types of cancer patterns, demonstrating robustness and adaptability.
Abstract:Motile nanosized particles, or "nanobots", promise more effective and less toxic targeted drug delivery because of their unique scale and precision. We consider the case in which the cancer is "diffuse", dispersed such that there are multiple distinct cancer sites. We investigate the problem of a swarm of nanobots locating these sites and treating them by dropping drug payloads at the sites. To improve the success of the treatment, the drug payloads must be allocated between sites according to their "demands"; this requires extra nanobot coordination. We present a mathematical model of the behavior of the nanobot agents and of their colloidal environment. This includes a movement model for agents based upon experimental findings from actual nanoparticles in which bots noisily ascend and descend chemical gradients. We present three algorithms: The first algorithm, called KM, is the most representative of reality, with agents simply following naturally existing chemical signals that surround each cancer site. The second algorithm, KMA, includes an additional chemical payload which amplifies the existing natural signals. The third algorithm, KMAR, includes another additional chemical payload which counteracts the other signals, instead inducing negative chemotaxis in agents such that they are repelled from sites that are already sufficiently treated. We present simulation results for all algorithms across different types of cancer arrangements. For KM, we show that the treatment is generally successful unless the natural chemical signals are weak, in which case the treatment progresses too slowly. For KMA, we demonstrate a significant improvement in treatment speed but a drop in eventual success, except for concentrated cancer patterns. For KMAR, our results show great performance across all types of cancer patterns, demonstrating robustness and adaptability.
Multiagent Systems (cs.MA); Robotics (cs.RO); Quantitative Methods (q-bio.QM)
arXiv:2509.06893 [cs.MA]
(or arXiv:2509.06893v2 [cs.MA] for this version)
https://doi.org/10.48550/arXiv.2509.06893 Focus to learn more arXiv-issued DOI via DataCite
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 374 words
Related coverage

News
Quantum Computing Report · Jun 7, 2026

Corporate and Government Early Adopters in Quantum Chemicals & Quantum Life Science
Inside Quantum Technology · Sep 2, 2026

Cancer May Behave Like a Quantum System, Columbia Studies Suggest
The Quantum Insider · Aug 27, 2026

Five of six Q4Bio finalists used IBM quantum hardware
Quantum Zeitgeist · Sep 24, 2026